EFTA02660113.pdf

From: jeffrey E. <[email protected]> Sent: Thursday, May 17, 2018 11:33 PM To: https://www.nytimes.com/2018/05/17/herlth/migraines-prevention-drug- aimovig.html?hp&action=click&pgtyp==Homepage&clickSource=story-heading&module=first-column- regi=n&region=top-news&VVT.nav=top-news <https://www.nytimes.com/2018/05/17/health/migra=nes-prevention- drug-aimovig.html?hp&action=click&pgtype=Homepa=e&clickSource=story-heading&module=first-column- region&reg=on=top-news&WT.nav=top-news> =br> =AO please note The information conta=ned in this communication is confidential, may be attorney-client privi=eged, may constitute inside information, and is intended only for th= use of the addressee. It is the property of _WE Unauthorized use, d=sclosure or copying of this communication or any part thereof is strict=y prohibited and may be unlawful. If you have received this communic=tion in error, please notify us immediately by return e-mail or by e-ma=l to [email protected] <[email protected]> , and destroy this communication and all copies thereof,<=r>including all attachments. copyright -all rights reserved --00000000000002ee9e056c6f404b-- conversation-id 6072 date-last-viewed 0 date-received 1526599953 flags 8590195713 gmail-label-ids 7 6 remote-id 822130 1 EFTA_R1_01907455 EFTA02660113